Early stage HCC patients (Stage I-II) demonstrated a greater degree of partially exhausted CD8+ TRM co-expressing ICOS, PD-1, TIGIT and Tim-3 (Figure 4 and Supplementary Figure 4). This evidence concerns the gene ICOS and hepatocellular carcinoma.